REGULATED PRESS RELEASE published on 04/20/2026 at 07:00, 3 months 29 days ago Uitnodiging voor de Jaarvergadering en Buitengewone Algemene Vergadering van aandeelhouders Uitnodiging voor de Jaarvergadering en Buitengewone Algemene Vergadering van aandeelhouders van TINC NV op 20 mei 2026 met beslissing over uitkering aan aandeelhouders. Gereglementeerde informatie Buitengewone Algemene Vergadering Jaarvergadering Aandeelhouders Uitkering TINC NV
REGULATED PRESS RELEASE published on 04/20/2026 at 07:00, 3 months 29 days ago Invitation to the Annual and Extraordinary General Meeting of Shareholders Invitation to the Annual and Extraordinary General Meeting of Shareholders of TINC NV on 20 May 2026 at BluePoint Antwerpen. Includes distribution of €0.59 per share. Visit www.tincinvest.com for details Shareholders General Meeting Distribution Invitation TINC NV
PRESS RELEASE published on 04/20/2026 at 07:00, 3 months 29 days ago RUBIS: Composition of the Supervisory Board Ronald Sämann resigns from Rubis' Supervisory Board for personal reasons. Marc-Olivier Laurent expresses gratitude for Sämann's contributions Resignation Supervisory Board RUBIS Marc-Olivier Laurent Ronald Sämann
PRESS RELEASE published on 04/20/2026 at 06:30, 3 months 29 days ago Formycon invites to Conference Call on the Results of the Financial Year 2025 and announces Participation in international Investor Conferences in the 2nd Quarter of 2026 Formycon AG to hold Conference Call on Results of FY 2025 and participate in international Investor Conferences in Q2 2026. Details and registration at provided links Conference Call Investor Conferences Formycon AG Biosimilars Financial Year 2025
PRESS RELEASE published on 04/20/2026 at 04:05, 3 months 29 days ago EPG Publishes Inaugural ESG Report, Establishing Baseline for Sustainable Global Expansion EPG releases inaugural ESG Report, setting base for global expansion with focus on environmental, social, and governance aspects. Company achieves compliance, diverse workforce, and inclusive governance Global Expansion Compliance Diversity ESG Report Inclusive Governance
PRESS RELEASE published on 04/20/2026 at 04:00, 3 months 29 days ago Leapmotor Selects QNX for D19 Premium Electric SUV, Production Starts April 2026 Leapmotor selects QNX technology for central controller in premium electric SUV. QNX SDP 8.0 and Hypervisor for Safety 8.0 enable next-gen experiences and safety features Safety Features Leapmotor QNX Technology Central Controller Premium Electric SUV
PRESS RELEASE published on 04/20/2026 at 02:25, 4 months ago First Challenger Assays Return Grades up to 170g/t Au New high-grade mineralisation discovered in open pit walls at Barton Gold Holdings Limited's Challenger Gold Project in South Australia High-grade Mineralisation Barton Gold Holdings Limited South Australia Challenger Gold Project Open Pit Walls
PRESS RELEASE published on 04/19/2026 at 23:18, 4 months ago KKO INTERNATIONAL ANNONCE LA SIGNATURE D’UN ACCORD ENGAGEANT EN VUE DE RÉALISER UNE OPÉRATION STRATÉGIQUE STRUCTURANTE AVEC LE GROUPE LACASA KKO INTERNATIONAL annonce la signature d'un accord stratégique avec le Groupe Lacasa pour une augmentation de capital et une joint-venture en Côte d'Ivoire Augmentation De Capital Accord Stratégique KKO International Joint-venture Groupe Lacasa
PRESS RELEASE published on 04/18/2026 at 12:00, 4 months 1 day ago Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe Le vaccin Nuvaxovid de Sanofi, contre la COVID-19, montre une meilleure tolérance que mNEXSPIKE dans une étude comparative présentée à l'ESCMID. Résultats significatifs pour améliorer la vaccination COVID-19 Sanofi Vaccin Tolérance Nuvaxovid
PRESS RELEASE published on 04/18/2026 at 12:00, 4 months 1 day ago Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study Sanofi's Nuvaxovid COVID-19 vaccine demonstrated better tolerability than mNEXSPIKE in a head-to-head study presented at ESCMID Global Congress. Results indicate lower side effects and improved patient experience COVID-19 Sanofi Vaccine Nuvaxovid Tolerability
Published on 08/20/2026 at 02:22, 25 minutes ago Infrastructure Sterilisation Drilling Begins at Tunkillia
Published on 08/20/2026 at 00:40, 2 hours 7 minutes ago Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Published on 08/19/2026 at 22:00, 4 hours 47 minutes ago Jaguar Health Reports Second Quarter 2026 Financials
Published on 08/19/2026 at 20:35, 6 hours 12 minutes ago Revive Therapeutics Announces Proposed Shares for Debt Settlement
Published on 08/20/2026 at 01:45, 1 hour 1 minute ago EQS-Adhoc: Dexus Finance Pty Limited: 2026 Annual results – Delivers on guidance and progresses key strategic actions
Published on 08/18/2026 at 18:00, 1 day 8 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 9 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 15 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 15 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 7 hours ago Aéroports de Paris S.A - July 2026 traffic figures